What lowers your risk
- Avoid asbestos exposure — there is no known safe level
- If your work involves older buildings, ships, insulation, brakes, or demolition, use every piece of protective equipment provided and follow OSHA asbestos procedures
- If you are exposed at work, shower and change before going home, and keep work clothes out of the household laundry — fibers carried home have caused disease in family members
- If you live near a former asbestos mine, mill or factory, or in an older home, test before any renovation that could disturb asbestos-containing material
- Tell your doctor about any past exposure, however long ago — the risk does not fade with time, and that history changes which symptoms should never be brushed off
Who is at higher risk
- People with occupational asbestos exposure — shipbuilding, insulation, construction, mining and milling, asbestos product manufacturing, brake and clutch repair, demolition
- Firefighters and disaster responders where asbestos-containing material was disturbed, including World Trade Center responders
- Family members of asbestos workers, from fibers carried home on clothing, skin and hair
- People living near asbestos mines or factories, without any direct occupational exposure
- People with a germline BAP1 mutation, which raises risk independent of how much exposure they had
There is no screening test — vigilance is the substitute
No imaging or blood test has been validated to screen for mesothelioma, for asbestos-exposed workers or for anyone else. It is a rare cancer and no test performs well enough at population level.
What exists instead is vigilance. If you have a known exposure history, tell every doctor you see. And if any of the symptoms below appear, ask to be evaluated promptly rather than watched over months. Because latency runs 10 to 40 years or more, a new symptom decades after exposure still deserves a full workup — and it is the exposure history that tells a clinician to look properly.
Signs worth reporting promptly
- Shortness of breath, or a new wheeze
- A cough that persists and keeps getting worse
- Chest pain or tightness
- Unexplained weight loss and loss of appetite
- Fatigue that does not improve, or unexplained anemia
- Trouble swallowing, or new swelling in the neck or face
What treatment involves
For a minority of patients whose disease is caught early and stays confined, surgery is part of treatment — usually pleurectomy/decortication, a lung-sparing operation that strips the diseased lining while leaving the lung, rather than the more extensive extrapleural pneumonectomy. Surgery is nearly always combined with chemotherapy and often radiation, because mesothelioma tends to come back locally.
Radiation's role became clearer through the IMPRINT approach: hemithoracic intensity-modulated radiation delivered to the whole chest-cavity lining after chemotherapy and lung-sparing surgery. In the prospective trial that established it, patients whose tumor could be resected and who then received this radiation had 59% two-year overall survival, against 25% in those whose tumor could not be resected, with median overall survival of 23.7 months and an acceptable rate of radiation lung inflammation (PMID 27325859). Radiation is also used simply to relieve chest-wall pain.
Most patients are not operable at diagnosis, and this is where the biggest recent shift has happened. Nivolumab plus ipilimumab — two immunotherapy drugs — was compared against standard platinum chemotherapy in CheckMate 743 and significantly extended survival: median overall survival 18.1 versus 14.1 months, and two-year survival 41% versus 27% (PMID 33485464). Longer follow-up held: three-year survival 23% versus 15% (PMID 35124183). It was FDA-approved in 2020 and is now standard first-line treatment for unresectable disease, whatever the subtype.
Honest framing: mesothelioma is usually found after it has spread within the chest, and it remains hard to cure. Being told your prognosis is measured in months rather than years is real information, not a verdict on how you spend that time. Many patients do meaningfully better than the median, and trials are actively changing the numbers.
Questions to ask your care team
- Is my tumor potentially resectable, and what would surgery plus radiation involve?
- Am I a candidate for nivolumab plus ipilimumab, or another immunotherapy approach?
- What does my cell type — epithelioid, sarcomatoid or biphasic — mean for my options and outlook?
- Am I eligible for a clinical trial?
- What can be done for breathlessness and chest pain right now, alongside treatment?
- Should my family be counseled about their own exposure history?
Where these numbers come from
Immunotherapy: CheckMate 743, The Lancet 2021 (PMID 33485464), three-year follow-up Annals of Oncology 2022 (PMID 35124183). Radiation: IMPRINT, Journal of Clinical Oncology 2016 (PMID 27325859). Exposure and risk: National Cancer Institute asbestos fact sheet. We left out several widely-repeated latency and incidence figures we could not trace to a primary source.
Talk with our team
If you have an asbestos history and new chest symptoms, do not wait it out.